NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
May 22 12:36PM ET
10.81
Dollar change
-0.31
Percentage change
-2.79
%
IndexRUT P/E- EPS (ttm)-1.42 Insider Own12.16% Shs Outstand45.68M Perf Week13.08%
Market Cap494.10M Forward P/E- EPS next Y-0.53 Insider Trans0.00% Shs Float40.15M Perf Month-17.79%
Income-55.06M PEG- EPS next Q-0.41 Inst Own40.49% Short Float25.75% Perf Quarter-27.93%
Sales17.36M P/S28.46 EPS this Y96.52% Inst Trans43.97% Short Ratio4.97 Perf Half Y-41.19%
Book/sh2.79 P/B3.87 EPS next Y-1225.00% ROA-54.19% Short Interest10.34M Perf Year71.59%
Cash/sh3.17 P/C3.41 EPS next 5Y- ROE-75.39% 52W Range3.52 - 23.40 Perf YTD-21.67%
Dividend Est.- P/FCF- EPS past 5Y11.01% ROI-41.90% 52W High-53.80% Beta0.91
Dividend TTM- Quick Ratio6.55 Sales past 5Y345.38% Gross Margin91.37% 52W Low207.10% ATR (14)1.18
Dividend Ex-Date- Current Ratio6.55 EPS Y/Y TTM-62.11% Oper. Margin-329.90% RSI (14)54.43 Volatility16.61% 13.75%
Employees160 Debt/Eq0.04 Sales Y/Y TTM-35.92% Profit Margin-317.13% Recom1.00 Target Price42.12
Option/ShortYes / Yes LT Debt/Eq0.03 EPS Q/Q-71.09% Payout- Rel Volume0.93 Prev Close11.12
Sales Surprise-100.00% EPS Surprise-67.35% Sales Q/Q-100.00% EarningsMay 13 AMC Avg Volume2.08M Price10.81
SMA209.24% SMA500.85% SMA200-14.59% Trades Volume973,846 Change-2.79%
Date Action Analyst Rating Change Price Target Change
May-20-25Initiated Roth Capital Buy $31
Oct-21-24Initiated Piper Sandler Overweight $35
May-17-24Initiated Oppenheimer Outperform $14
Jan-05-24Initiated Cantor Fitzgerald Overweight $8
Oct-26-22Initiated Ladenburg Thalmann Buy $15
Dec-26-18Downgrade Maxim Group Buy → Hold
Jan-26-18Reiterated H.C. Wainwright Buy $6.50 → $8.60
Sep-15-17Reiterated H.C. Wainwright Buy $2.15 → $6.50
Feb-13-17Resumed Rodman & Renshaw Buy $14
Jul-06-16Resumed H.C. Wainwright Buy $13
May-21-25 11:22AM
May-14-25 03:15AM
May-13-25 04:19PM
04:05PM
09:00AM
09:37AM Loading…
May-12-25 09:37AM
May-06-25 09:15AM
May-05-25 08:00AM
Apr-21-25 05:02PM
08:00AM
Apr-01-25 09:00AM
Mar-21-25 06:23PM
Mar-20-25 04:41PM
10:21AM
Mar-19-25 06:57PM
06:56PM Loading…
06:56PM
05:15PM
04:17PM
04:05PM
Mar-18-25 09:31AM
Mar-17-25 09:25AM
Mar-11-25 09:00AM
Mar-10-25 09:13AM
Mar-07-25 09:25AM
Mar-06-25 06:20PM
Mar-04-25 11:21AM
07:00AM
Feb-25-25 12:35PM
Feb-10-25 09:00AM
Jan-16-25 09:55AM
09:15AM Loading…
Jan-02-25 09:15AM
Dec-02-24 04:15PM
Nov-20-24 09:00AM
Nov-16-24 01:28AM
Nov-14-24 09:49AM
Nov-13-24 05:10PM
04:07PM
04:01PM
Nov-12-24 09:00AM
Nov-07-24 09:40AM
Nov-05-24 10:00AM
09:00AM
Oct-18-24 04:01PM
Oct-17-24 06:00AM
Oct-16-24 04:17PM
Oct-14-24 08:12AM
Oct-11-24 12:18PM
09:15AM
Oct-09-24 05:17PM
09:15AM
Oct-08-24 09:55AM
Oct-04-24 09:15AM
Oct-03-24 05:07AM
Sep-24-24 08:00AM
07:37AM
Sep-23-24 09:25AM
Sep-17-24 09:15AM
09:07AM
Sep-06-24 08:30AM
Aug-07-24 05:25PM
04:22PM
04:05PM
Jul-31-24 09:00AM
Jul-01-24 09:00AM
06:12AM
Jun-28-24 09:00AM
Jun-25-24 10:30AM
08:30AM
Jun-11-24 09:25AM
Jun-10-24 09:38AM
Jun-04-24 09:00AM
May-17-24 07:59AM
May-14-24 08:20AM
03:04AM
May-13-24 09:54PM
05:15PM
04:17PM
04:05PM
May-09-24 09:15AM
May-08-24 09:00AM
May-06-24 09:00AM
Apr-24-24 03:21PM
09:00AM
Apr-10-24 09:55AM
Mar-25-24 09:55AM
Mar-21-24 08:30AM
Mar-07-24 09:55AM
Mar-06-24 08:30AM
Mar-02-24 08:17AM
Mar-01-24 06:06AM
Feb-29-24 04:42PM
04:35PM
04:05PM
Feb-27-24 08:30AM
Feb-22-24 08:30AM
Feb-20-24 08:30AM
Jan-24-24 09:15AM
Dec-11-23 09:00AM
Nov-16-23 08:28AM
Nov-14-23 04:30PM
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy ("DMD"), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Marban LindaCHIEF EXECUTIVE OFFICERMar 03 '25Option Exercise1.3925,00034,750223,604Mar 05 05:00 PM
Bergmann AnthonyCHIEF FINANCIAL OFFICERMar 03 '25Option Exercise1.392,5003,4758,223Mar 04 07:00 PM
Litvack FrankDirectorMar 03 '25Option Exercise1.3925,00034,750132,382Mar 04 07:00 PM
DUNBAR GEORGE W JRDirectorMar 03 '25Option Exercise1.397501,04211,306Mar 04 07:00 PM
COLLIER EARL M JRDirectorFeb 27 '25Option Exercise1.397501,04257,606Feb 28 07:30 PM
Krasney KarenEVP, GENERAL COUNSELDec 13 '24Option Exercise1.398,00011,12028,047Dec 16 09:25 AM
Litvack FrankDirectorDec 03 '24Option Exercise1.1020,39122,43046,278Dec 04 08:00 PM
Nippon Shinyaku Co Ltd10% OwnerSep 20 '24Buy5.362,798,50714,999,9987,090,351Sep 24 04:01 PM
Musket David BDirectorAug 07 '24Option Exercise1.3934,00047,26081,692Aug 09 09:00 AM